- 期刊
Appropriate Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Atherosclerotic Cardiovascular Disease: Comparison of Recommendations from Different Guidelines or Consensus Around the World
摘要
Increased low-density lipoprotein cholesterol (LDL-C) is the most crucial risk factor for atherosclerotic cardiovascular disease (ASCVD). Statins are the mainstay therapy, but many patients need to add non-statin treatment to reach the recommended LDL-C goal. Although proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are the most effective agents in LDL-C reduction, they are much more expensive than other lipid-lowering agents. In January 2020, the Taiwan National Health Insurance (NHI) program started to reimburse PCSK9 inhibitors for select ASCVD patients with certain conditions. Major guidelines or consensus worldwide also provide specific recommendations about how to appropriately use these agents. This review summarizes the Taiwan NHI regulations of using PCSK9 inhibitors and compared them with other guidelines or consensus around the world.
延伸閱讀
- Ko, W. C. (2011). Connective Tissue Growth Factor and Cardiovascular Disease－Focusing on the Mechanisms of Structural Remodeling in Atrial Fibrillation and Atherothrombosis [doctoral dissertation, Taipei Medical University]. Airiti Library. https://doi.org/10.6831/TMU.2011.00076
- Yeh, H. M. (2022). Association between Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and the Risk of Cardiovascular Diseases in Advanced Non-Small Cell Lung Cancer [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202201880
- Lobbes, M. B. I., Kooi, M. E., Lutgens, E., Ruiters, A. W., Passos, V. L., Braat, S. H. J. G., Rousch, M., Cate, H. T., Engelshoven, J. M. A. V., Daemen, M. J. A. P., & Heeneman, S. (2010). Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach. International Journal of Vascular Medicine, 2010(), 48-56. https://doi.org/10.1155/2010/726207
- Asrih, M., Mach, F., Nencioni, A., Dallegri, F., Quercioli, A., & Montecucco, F. (2013). Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome. Mediators of Inflammation, 2013(), 94-104-109. https://doi.org/10.1155/2013/367245
- Lin, H. J. (2020). The identification and application of novel biomarkers to improve clinical risk profiling of atherosclerotic cardiovascular diseases [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202002997